Symbols / SIBN Stock $15.92 +0.49% SI-BONE, Inc.

Healthcare • Medical Devices • United States • NGM
SIBN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Ms. Laura A. Francis MBA
Exch · Country NGM · United States
Market Cap 705.93M
Enterprise Value 600.76M
Income -16.70M
Sales 206.22M
FCF (ttm) -2.65M
Book/sh 4.05
Cash/sh 3.26
Employees 376
Insider 10d —
IPO Oct 17, 2018
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -45.11
PEG —
P/S 3.42
P/B 3.93
P/C —
EV/EBITDA -43.43
EV/Sales 2.91
Quick Ratio 8.20
Current Ratio 9.99
Debt/Eq 24.00
LT Debt/Eq —
EPS (ttm) -0.39
EPS next Y -0.35
EPS Growth —
Revenue Growth 11.20%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-03
Earnings (prior) 2026-05-11
ROA -5.30%
ROE -9.64%
ROIC —
Gross Margin 79.59%
Oper. Margin -9.69%
Profit Margin -8.10%
Shs Outstand 44.35M
Shs Float 42.78M
Insider Own 3.42%
Instit Own 108.16%
Short Float 15.48%
Short Ratio 6.89
Short Interest 5.88M
52W High 21.89
vs 52W High -27.28%
52W Low 11.48
vs 52W Low 38.65%
Beta 0.70
Impl. Vol. 59.72%
Rel Volume 0.12
Avg Volume 669.02K
Volume 83.54K
Target (mean) $24.12
Tgt Median $24.00
Tgt Low $18.00
Tgt High $32.00
# Analysts 8
Recom None
Prev Close $15.84
Price $15.92
Change 0.49%
About

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$24.13
Mean price target
2. Current target
$15.92
Latest analyst target
3. DCF / Fair value
$-1.08
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$15.92
Low
$18.00
High
$32.00
Mean
$24.13

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-12 main TD Cowen Buy → Buy $18
2026-05-12 reit Truist Securities Buy → Buy $18
2026-04-15 main Truist Securities Buy → Buy $20
2026-02-24 main TD Cowen Buy → Buy $22
2026-02-24 reit Truist Securities Buy → Buy $24
2026-01-27 init TD Cowen — → Buy $21
2025-12-18 main Truist Securities Buy → Buy $23
2025-12-17 main Canaccord Genuity Buy → Buy $27
2025-12-16 main Needham Buy → Buy $27
2025-12-02 main Morgan Stanley Overweight → Overweight $23
2025-10-15 main Truist Securities Buy → Buy $20
2025-08-05 reit Cantor Fitzgerald Overweight → Overweight $25
2025-05-06 main Truist Securities Buy → Buy $22
2025-05-06 reit Cantor Fitzgerald Overweight → Overweight $25
2025-05-06 reit Needham Buy → Buy $24
2025-02-25 reit Citizens Capital Markets Market Outperform → Market Outperform $32
2025-02-25 reit Truist Securities Buy → Buy $22
2025-02-25 reit Cantor Fitzgerald Overweight → Overweight $25
2025-02-25 main Needham Buy → Buy $24
2025-01-13 reit Needham Buy → Buy $19
News
RSS: Latest SIBN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-06-05 DUNN JEFFREY W Director — 3,575 $15.25 $54,505
2026-06-04 DUNN JEFFREY W Director — 10,957 $0.00 $0
2026-06-04 NISHIMURA MIKA Director — 10,957 $0.00 $0
2026-06-04 WEST THOMAS A Director — 10,957 $0.00 $0
2026-06-04 HILLEMAN JERYL L Director — 10,957 $0.00 $0
2026-06-04 FREUND JOHN GORDON Director — 10,957 $0.00 $0
2026-06-04 DAVIS TIMOTHY E JR Director — 10,957 $0.00 $0
2026-05-29 DAVIS TIMOTHY E JR Director — 7,280 $14.14 $104,187
2026-05-28 DAVIS TIMOTHY E JR Director — 12,064 $4.32 $52,116
2026-05-18 PISETSKY MICHAEL A Officer — 3,726 $14.63 $54,527
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
200.93
+20.19%
167.18
+20.37%
138.89
+30.52%
106.41
Operating Revenue
200.93
+20.19%
167.18
+20.37%
138.89
+30.52%
106.41
Cost Of Revenue
41.05
+17.08%
35.06
+18.97%
29.47
+87.62%
15.71
Reconciled Cost Of Revenue
41.05
+17.08%
35.06
+18.97%
29.47
+87.62%
15.71
Gross Profit
159.88
+21.01%
132.12
+20.75%
109.42
+20.63%
90.70
Operating Expense
182.21
+8.87%
167.37
+7.05%
156.35
+4.02%
150.31
Research And Development
17.45
+5.36%
16.56
+10.19%
15.03
+10.28%
13.63
Selling General And Administration
164.76
+9.25%
150.81
+6.71%
141.32
+3.39%
136.69
Selling And Marketing Expense
124.22
+6.13%
117.05
+6.17%
110.25
+2.35%
107.73
General And Administrative Expense
40.54
+20.09%
33.76
+8.65%
31.07
+7.28%
28.96
Other Gand A
40.54
+20.09%
33.76
+8.65%
31.07
+7.28%
28.96
Total Expenses
223.25
+10.29%
202.43
+8.94%
185.82
+11.93%
166.02
Operating Income
-22.33
+36.65%
-35.25
+24.89%
-46.93
+21.27%
-59.61
Total Operating Income As Reported
-22.33
+36.65%
-35.25
+24.89%
-46.93
+21.27%
-59.61
EBITDA
-10.51
+54.51%
-23.09
+32.96%
-34.45
+37.35%
-54.98
Normalized EBITDA
-10.51
+54.51%
-23.09
+32.96%
-34.45
+37.35%
-54.98
Reconciled Depreciation
5.77
+31.77%
4.38
-19.33%
5.43
+57.24%
3.45
EBIT
-16.28
+40.76%
-27.47
+31.10%
-39.87
+31.77%
-58.44
Net Income
-18.90
+38.85%
-30.91
+28.67%
-43.34
+29.25%
-61.26
Pretax Income
-18.90
+38.85%
-30.91
+28.67%
-43.34
+29.25%
-61.26
Net Non Operating Interest Income Expense
3.45
-21.82%
4.41
+27.62%
3.45
+327.99%
-1.51
Interest Expense Non Operating
2.63
-23.60%
3.44
-0.64%
3.46
+22.81%
2.82
Net Interest Income
3.45
-21.82%
4.41
+27.62%
3.45
+327.99%
-1.51
Interest Expense
2.63
-23.60%
3.44
-0.64%
3.46
+22.81%
2.82
Interest Income Non Operating
6.07
-22.60%
7.85
+13.48%
6.92
+430.37%
1.30
Interest Income
6.07
-22.60%
7.85
+13.48%
6.92
+430.37%
1.30
Other Income Expense
-0.02
+72.60%
-0.07
-151.77%
0.14
+206.82%
-0.13
Other Non Operating Income Expenses
-0.02
+72.60%
-0.07
-151.77%
0.14
+206.82%
-0.13
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-18.90
+38.85%
-30.91
+28.67%
-43.34
+29.25%
-61.26
Net Income From Continuing Operation Net Minority Interest
-18.90
+38.85%
-30.91
+28.67%
-43.34
+29.25%
-61.26
Net Income From Continuing And Discontinued Operation
-18.90
+38.85%
-30.91
+28.67%
-43.34
+29.25%
-61.26
Net Income Continuous Operations
-18.90
+38.85%
-30.91
+28.67%
-43.34
+29.25%
-61.26
Normalized Income
-18.90
+38.85%
-30.91
+28.67%
-43.34
+29.25%
-61.26
Net Income Common Stockholders
-18.90
+38.85%
-30.91
+28.67%
-43.34
+29.25%
-61.26
Diluted EPS
-0.44
+41.33%
-0.75
+33.63%
-1.13
+36.87%
-1.79
Basic EPS
-0.44
+41.33%
-0.75
+33.63%
-1.13
+36.87%
-1.79
Basic Average Shares
42.96
+3.60%
41.47
+7.91%
38.43
+12.35%
34.20
Diluted Average Shares
42.96
+3.60%
41.47
+7.91%
38.43
+12.35%
34.20
Diluted NI Availto Com Stockholders
-18.90
+38.85%
-30.91
+28.67%
-43.34
+29.25%
-61.26
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
238.56
+3.52%
230.44
+0.01%
230.43
+46.25%
157.55
Current Assets
216.12
+4.01%
207.78
-1.71%
211.39
+53.62%
137.61
Cash Cash Equivalents And Short Term Investments
147.82
-1.48%
150.04
-9.62%
166.02
+70.64%
97.29
Cash And Cash Equivalents
42.24
+20.87%
34.95
+5.04%
33.27
+60.60%
20.72
Other Short Term Investments
105.58
-8.26%
115.09
-13.30%
132.75
+73.36%
76.57
Receivables
29.91
+8.94%
27.46
+25.08%
21.95
+6.19%
20.67
Accounts Receivable
29.91
+8.94%
27.46
+25.08%
21.95
+6.19%
20.67
Gross Accounts Receivable
30.93
+10.27%
28.05
+21.57%
23.07
+9.48%
21.07
Allowance For Doubtful Accounts Receivable
-1.01
-72.28%
-0.59
+47.41%
-1.12
-179.50%
-0.40
Inventory
33.90
+25.20%
27.07
+33.71%
20.25
+17.17%
17.28
Work In Process
4.00
+29.03%
3.10
+121.43%
1.40
-17.65%
1.70
Finished Goods
29.90
+24.58%
24.00
+27.66%
18.80
+20.51%
15.60
Prepaid Assets
—
—
—
—
Other Current Assets
4.48
+39.83%
3.20
+0.98%
3.17
+34.16%
2.37
Total Non Current Assets
22.44
-0.96%
22.66
+19.06%
19.03
-4.56%
19.94
Net PPE
22.39
+0.12%
22.36
+19.52%
18.71
-4.40%
19.57
Gross PPE
44.93
+7.24%
41.90
+23.41%
33.95
+14.04%
29.77
Accumulated Depreciation
-22.55
-15.38%
-19.54
-28.17%
-15.25
-49.37%
-10.21
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
8.34
+24.97%
6.67
+25.60%
5.31
+66.31%
3.19
Construction In Progress
5.90
-5.01%
6.21
+61.10%
3.86
-50.90%
7.85
Other Properties
26.82
+6.67%
25.14
+20.23%
20.91
+22.33%
17.09
Leases
3.87
+0.00%
3.87
+0.00%
3.87
+137.46%
1.63
Other Non Current Assets
0.06
-81.67%
0.30
-7.69%
0.33
-13.33%
0.38
Total Liabilities Net Minority Interest
61.02
-3.86%
63.47
+3.97%
61.05
+3.04%
59.25
Current Liabilities
25.28
-6.83%
27.13
+15.67%
23.46
+10.76%
21.18
Payables And Accrued Expenses
9.55
-14.14%
11.13
+47.12%
7.56
+1.50%
7.45
Payables
4.63
-28.62%
6.49
+41.41%
4.59
-26.93%
6.28
Accounts Payable
4.63
-28.62%
6.49
+41.41%
4.59
-26.93%
6.28
Current Accrued Expenses
4.92
+6.10%
4.64
+55.91%
2.98
+153.71%
1.17
Pensionand Other Post Retirement Benefit Plans Current
13.90
-0.09%
13.91
+3.34%
13.46
+18.47%
11.37
Current Debt And Capital Lease Obligation
0.94
-18.06%
1.15
-18.64%
1.42
+2.02%
1.39
Current Capital Lease Obligation
0.94
-18.06%
1.15
-18.64%
1.42
+2.02%
1.39
Other Current Liabilities
0.88
-6.29%
0.94
-7.31%
1.01
+4.01%
0.97
Total Non Current Liabilities Net Minority Interest
35.74
-1.64%
36.34
-3.33%
37.59
-1.26%
38.07
Long Term Debt And Capital Lease Obligation
35.74
-1.62%
36.33
-3.31%
37.58
-1.22%
38.04
Long Term Debt
35.57
+0.33%
35.45
-1.70%
36.06
+2.54%
35.17
Long Term Capital Lease Obligation
0.17
-80.09%
0.88
-41.83%
1.51
-47.37%
2.87
Other Non Current Liabilities
—
0.01
-44.44%
0.02
-40.00%
0.03
Stockholders Equity
177.53
+6.33%
166.96
-1.42%
169.38
+72.30%
98.30
Common Stock Equity
177.53
+6.33%
166.96
-1.42%
169.38
+72.30%
98.30
Capital Stock
0.00
+0.00%
0.00
+0.00%
0.00
+33.33%
0.00
Common Stock
0.00
+0.00%
0.00
+0.00%
0.00
+33.33%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
43.65
+3.71%
42.09
+3.42%
40.69
+17.17%
34.73
Ordinary Shares Number
43.65
+3.71%
42.09
+3.42%
40.69
+17.17%
34.73
Additional Paid In Capital
626.97
+4.83%
598.07
+5.02%
569.48
+25.11%
455.17
Retained Earnings
-450.26
-4.38%
-431.35
-7.72%
-400.44
-12.14%
-357.11
Gains Losses Not Affecting Retained Earnings
0.82
+234.43%
0.24
-27.16%
0.34
+44.40%
0.23
Total Equity Gross Minority Interest
177.53
+6.33%
166.96
-1.42%
169.38
+72.30%
98.30
Total Capitalization
213.10
+5.28%
202.42
-1.47%
205.44
+53.92%
133.47
Working Capital
190.84
+5.64%
180.65
-3.88%
187.94
+61.41%
116.43
Invested Capital
213.10
+5.28%
202.42
-1.47%
205.44
+53.92%
133.47
Total Debt
36.69
-2.12%
37.48
-3.87%
38.99
-1.11%
39.43
Net Debt
—
0.50
-81.96%
2.79
-80.67%
14.45
Capital Lease Obligations
1.12
-44.90%
2.03
-30.61%
2.93
-31.27%
4.26
Net Tangible Assets
177.53
+6.33%
166.96
-1.42%
169.38
+72.30%
98.30
Tangible Book Value
177.53
+6.33%
166.96
-1.42%
169.38
+72.30%
98.30
Other Inventories
-0.00
+88.46%
-0.03
-153.06%
0.05
+372.22%
-0.02
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-0.68
+94.57%
-12.43
+33.60%
-18.71
+55.08%
-41.66
Cash Flow From Continuing Operating Activities
-0.68
+94.57%
-12.43
+33.60%
-18.71
+55.08%
-41.66
Net Income From Continuing Operations
-18.90
+38.85%
-30.91
+28.67%
-43.34
+29.25%
-61.26
Depreciation Amortization Depletion
5.77
+31.77%
4.38
-19.33%
5.43
+57.24%
3.45
Depreciation
5.80
—
—
—
Depreciation And Amortization
5.77
+31.77%
4.38
-19.33%
5.43
+57.24%
3.45
Other Non Cash Items
0.69
+10.27%
0.62
-35.71%
0.97
+178.45%
0.35
Stock Based Compensation
25.52
-1.33%
25.87
+7.53%
24.06
+4.32%
23.06
Provisionand Write Offof Assets
2.00
+53.62%
1.30
-23.93%
1.71
+435.74%
0.32
Asset Impairment Charge
—
—
—
—
Operating Gains Losses
1.63
-13.32%
1.88
+44.16%
1.30
+750.98%
0.15
Gain Loss On Sale Of PPE
1.63
-13.32%
1.88
+44.16%
1.30
+750.98%
0.15
Change In Working Capital
-14.32
-41.55%
-10.12
-109.39%
-4.83
+39.29%
-7.96
Change In Receivables
-3.03
+48.17%
-5.84
-175.21%
-2.12
+67.25%
-6.48
Changes In Account Receivables
-3.03
+48.17%
-5.84
-175.21%
-2.12
+67.25%
-6.48
Change In Inventory
-8.68
-7.92%
-8.05
-70.52%
-4.72
+21.72%
-6.03
Change In Prepaid Assets
-1.03
-51400.00%
-0.00
+99.74%
-0.76
-194.07%
0.81
Change In Payables And Accrued Expense
-1.58
-142.03%
3.77
+36.06%
2.77
-25.86%
3.74
Change In Accrued Expense
0.18
-90.62%
1.91
-50.93%
3.89
+222.12%
1.21
Change In Payable
-1.76
-194.73%
1.86
+266.46%
-1.12
-144.21%
2.53
Change In Account Payable
-1.76
-194.73%
1.86
+266.46%
-1.12
-144.21%
2.53
Investing Cash Flow
4.16
-67.04%
12.62
+121.11%
-59.80
-2024.26%
-2.81
Cash Flow From Continuing Investing Activities
4.16
-67.04%
12.62
+121.11%
-59.80
-2024.26%
-2.81
Net PPE Purchase And Sale
-8.41
+19.84%
-10.50
-34.59%
-7.80
+17.97%
-9.51
Purchase Of PPE
-8.41
+19.84%
-10.50
-34.59%
-7.80
+17.97%
-9.51
Capital Expenditure
-8.41
+19.84%
-10.50
-34.59%
-7.80
+17.97%
-9.51
Net Investment Purchase And Sale
12.57
-45.61%
23.12
+144.46%
-52.00
-877.03%
6.69
Purchase Of Investment
-192.53
+6.26%
-205.38
-8.38%
-189.50
-58.57%
-119.51
Sale Of Investment
205.10
-10.24%
228.50
+66.18%
137.50
+8.95%
126.20
Financing Cash Flow
3.38
+72.42%
1.96
-97.85%
90.93
+4038.96%
2.20
Cash Flow From Continuing Financing Activities
3.38
+72.42%
1.96
-97.85%
90.93
+4038.96%
2.20
Net Issuance Payments Of Debt
0.00
+100.00%
-0.05
-106.72%
0.69
0.00
Issuance Of Debt
0.00
-100.00%
35.95
-0.02%
35.96
0.00
Repayment Of Debt
0.00
+100.00%
-36.00
-2.06%
-35.27
0.00
Long Term Debt Issuance
0.00
-100.00%
35.95
-0.02%
35.96
0.00
Long Term Debt Payments
0.00
+100.00%
-36.00
-2.06%
-35.27
0.00
Net Long Term Debt Issuance
0.00
+100.00%
-0.05
-106.72%
0.69
0.00
Net Common Stock Issuance
0.00
0.00
-100.00%
83.67
0.00
Proceeds From Stock Option Exercised
3.38
+23.94%
2.72
-58.58%
6.58
+199.36%
2.20
Net Other Financing Charges
—
-0.72
-1700.00%
-0.04
—
Changes In Cash
6.86
+218.23%
2.16
-82.64%
12.42
+129.39%
-42.27
Effect Of Exchange Rate Changes
0.43
+189.98%
-0.48
-462.88%
0.13
+130.77%
-0.43
Beginning Cash Position
34.95
+5.04%
33.27
+60.60%
20.72
-67.33%
63.42
End Cash Position
42.24
+20.87%
34.95
+5.04%
33.27
+60.60%
20.72
Free Cash Flow
-9.09
+60.35%
-22.92
+13.54%
-26.51
+48.18%
-51.16
Interest Paid Supplemental Data
2.53
-24.30%
3.35
+2.54%
3.26
+24.49%
2.62
Amortization Of Securities
-3.05
+43.92%
-5.44
-35.69%
-4.01
-1850.66%
0.23
Common Stock Issuance
0.00
0.00
-100.00%
83.67
0.00
Issuance Of Capital Stock
0.00
0.00
-100.00%
83.67
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category